Quote:

---

What if Merck is the one asking for the trial? Does the hold just go away if Pfizer wants LL for Long Haulers?

---

Money and potential future jobs for FDA employees could certainly affect the outcome of the hold.

Quote:

---

One must understand, if we try to do any trial ourselves we will fail, there is no win. If we have good numbers, or even an approval, there will be new hurtles on use, on manufacturing, on distribution.

---

I would disagree with that assessment. Highly positive numbers will get attention, especially concerning a disease that has no approved treatment. Attention means share price increase and an easier path to get money for the rest of the process or a possible buyout offer. On approval the FDA will already have a dosage and usage set up. For manufacturing the FDA has already approved the process but they'll be doing inspections. With distribution, companies will be knocking down the door trying to get a piece of that pie.